The life-threatening dangers of long flu — from diabetes risk to brain inflammation It’s believed that around three to five percent of people who get the flu may develop longterm symptoms The Independent UK · Sep 29
Ozempic Is Now Fighting America's Addiction Crisis — A Massive VA Study Covering 600,000 Veterans Is Rewriting What We Know About Substance Abuse Drugs like Ozempic and Wegovy — already reshaping obesity treatment — may also slash overdose deaths, ER visits, and alcohol dependence, according to the largest study ever conducted on GLP-1s and addiction. Medical Daily · Jun 6
Stopping GLP-1s can reverse cardiovascular benefits within six months, study finds Discontinuing the drugs leaves a ‘lasting scar,’ researchers at WashU Medicine say The Independent UK · Mar 19
GLP-1s could help curb substance abuse – including alcohol and opioids, new study finds Increasingly popular GLP-1 drugs used to treat diabetes and obesity show promise in fighting multiple substance use disorders The Independent UK · Mar 4
Weight-loss jabs linked to reduced risk of 42 conditions including dementia Psychotic disorders also among conditions found less likely when people with diabetes took medications found in jabs The Guardian - UK · Jan 20, 2025
Ozempic-style drugs tied to more than 60 health benefits and risks in biggest study-of-its-kind A large new study has shed light on the wider health impacts of taking Ozempic-style drugs. LiveScience · Jan 20, 2025
Huge Ozempic and GLP-1 drug study finds they may lower risk of 42 health conditions, including heart attacks and Alzheimer’s disease The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 receptor agonists. Fortune · Jan 20, 2025
COVID-19 raises the stakes for heart attacks, strokes, and even death long after infection, new study finds 'You may have forgotten that you had COVID years ago, but it has not forgotten about you.' Fortune · Oct 11, 2024
Long COVID is still a problem, racking up a global cost of $1 trillion Experts want government agencies to act. Fortune · Aug 9, 2024
COVID's impact lingers even after 3 years post infection, a new study has found A level of information has been unlocked with the new research indicating that the impact of the Covid-19 virus goes well beyond the initial infection, demonstrating the long-lasting impact the pandemic has had on world health. According to an investigation that was published in Nature Medicine, people can still have… The Times of India · May 30, 2024
COVID can cause new health problems even 3 years after infection, study finds. 'We don’t know what’s going to happen at 10 years' A new report reinforces that the virus is not going away. Fortune · May 30, 2024
Long COVID patients confront Congress Millions have been devastated by long COVID. Experts say it needs to be an urgent government priority Salon · Jan 20, 2024
Doctors Discover People Can Catch ‘long Flu’ Just Like Long COVID People hospitalized with the flu can suffer long-term, negative health effects – especially relating to their lungs and airways. Zenger · Dec 15, 2023
'Long-Flu': People Hospitalized With Seasonal Influenza May Suffer Negative Health Effects Similar To Long-COVID The study showed that patients hospitalized with flu or COVID-19 had an increased risk of death, hospital readmission and issues to multiple organs in the months following the infection. Medical Daily · Dec 15, 2023
Fortune · Dec 14, 2023 COVID-19 v. Flu: A ‘much more serious threat,’ new study into long-term risks concludes ‘We trivialize COVID infections at our peril,’ says the author of the study.
LiveScience · Dec 14, 2023 'Long flu' is real, and we've likely 'ignored it for a long time' Both COVID-19 and the flu can come with a long-term, heightened risk of death, hospital readmission and health issues affecting multiple organ systems.
The Guardian - UK · Dec 14, 2023 ‘Long flu’: study finds flu patients at higher risk of longer-term illness Like Covid, flu carries significant risk of ongoing disability and disease, researchers say
WEKU · Nov 13, 2023 Pain, fatigue, fuzzy thinking: How long COVID disrupts the brain The neurological symptoms of COVID can persist for years after an infection. Scientists are just beginning to understand why.
The Conversation · Sep 3, 2023 Long COVID symptoms can improve, but their resolution is slow and imperfect Around 5–10% of people who get infected with SARS-CoV-2 will experience symptoms that persist way beyond the initial acute period, a clinical syndrome we are learning more about, known widely as long COVID.
Fortune · Aug 21, 2023 Long COVID. Shorter Life? New research reveals an arduous road to recovery The first study to look at two years of data shows the devastating effects of long COVID-but there are still no validated treatments.
The Independent UK · Aug 10, 2023 COVID-19 took a toll on heart health and doctors are still grappling with how to help COVID-19 has taken a toll on the nation's heart health but how profound is only starting to emerge
Tribune News Service · May 23, 2023 COVID kills 1 person every 4 minutes as vaccine rates fall After more than three years, the global COVID-19 emergency is officially over. Yet it’s still killing at least one person every four minutes and questions on how to deal with the virus remain unanswered, putting vulnerable people and undervaccinated countries at risk.
WEKU · Apr 14, 2023 You're less likely to get long COVID after a second infection than a first The chances of developing lingering symptoms after COVID appears to fall sharply from the first to the second time someone gets sick, new research finds. The risk is still significant.
Tribune News Service · Apr 7, 2023 COVID-19 is still deadlier for patients than flu COVID-19 isn’t “just a flu,” with a study of hospital patients finding that the virus was still 60% deadlier than influenza last winter.
The Guardian - US · Jan 23, 2023 Does Covid reinfection bring more health risks – or make you ‘super immune’? The debate over the risks of reinfections – which are likely to continue – could determine what precautions people take, but experts disagree on the data